Abstract

A 44-year-old man was referred to our hospital for therapy for an esophageal hemangioma that had increased remarkably in size over three years of endoscopic follow-up.Although the patient had no history of dysphagia or hematemesis, prophylactic removal of the tumor was planned to prevent hemorrhage. The hemangioma was treated successfully by two rounds of endoscopic injection sclerotherapy(EIS)using 5% monoethanolamine oleate.Only mild chest pain was noted during therapy. Esophageal hemangioma is a rare disease that may cause bleeding or difficulty eating.Surgical resection, endoscopic mucosal resection,endoscopic submucosal dissection,and laser therapy have all been reported as treatment measures for these lesions.We opted for EIS in the present case because of its low invasiveness and ability to treat lesions protruding from the esophageal wall.Blood flow volume and the precise location of the tumor in the esophageal wall should be evaluated by imaging examinations when deciding on the treatment for esophageal hemangioma.Shinshu Med J 64 : 75―78, 2016 (Received for publication November 18,2015;accepted in revised form December 8,2015)

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call